Sichuan Biokin Pharmaceutical Co., Ltd.SSE: 688506

Notice on Convening the 1st Extraordinary General Meeting in 2026

· Issued by Sichuan Biokin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

The meeting is scheduled to take place in February and will include both onsite and online voting options for shareholders. Shareholders must register in advance to attend the meeting and can delegate their voting rights to a proxy if necessary.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Sichuan Biokin Pharmaceutical Co., Ltd. on 6ix

Earlier from Sichuan Biokin Pharmaceutical

Later from Sichuan Biokin Pharmaceutical

All Sichuan Biokin Pharmaceutical news releases